Evogene（NASDAQ:EVGN）報告季度每股收益為$0.06，超過分析師共識預期的$(0.72)，高出108.33%。這比去年同期每股虧損$(1.30)增加了104.62%。公司報告季度銷售額為$161萬，未達到分析師共識預期的$363萬，低了55.56%。這比去年同期的$57.8萬增加了178.72%。

以上內容來自Benzinga Earnings專欄，原文如下：

Evogene (NASDAQ:EVGN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.72) by 108.33 percent. This is a 104.62 percent increase over losses of $(1.30) per share from the same period last year. The company reported quarterly sales of $1.61 million which missed the analyst consensus estimate of $3.63 million by 55.56 percent. This is a 178.72 percent increase over sales of $578.00 thousand the same period last year.